|Other Names||Alkylglycerol monooxygenase, Transmembrane protein 195, AGMO, TMEM195|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13099a was selected from the N-term region of TMEM195. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes.|
|Cellular Location||Endoplasmic reticulum membrane; Multi-pass membrane protein|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes.
Fontaine-Bisson, B., et al. Diabetologia 53(10):2155-2162(2010)Watschinger, K., et al. Proc. Natl. Acad. Sci. U.S.A. 107(31):13672-13677(2010)Boesgaard, T.W., et al. Diabetologia 53(8):1647-1655(2010)Akiyama, K., et al. J. Hum. Genet. (2010) In press :Dupuis, J., et al. Nat. Genet. 42(2):105-116(2010)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.